$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

A novel glycoprotein D-specific monoclonal antibody neutralizes herpes simplex virus 원문보기

Antiviral research, v.147, 2017년, pp.131 - 141  

Du, Ruikun (Corresponding author. State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Xiaohongshan 44, Wuchang, Wuhan, 430071, PR China.) ,  Wang, Lili ,  Xu, Hao ,  Wang, Zhiying ,  Zhang, Tao ,  Wang, Manli ,  Ning, Yunjia ,  Deng, Fei ,  Hu, Zhihong ,  Wang, Hualin ,  Li, Yi

Abstract AI-Helper 아이콘AI-Helper

Abstract The worldwide prevalence of herpes simplex virus (HSV) and the shortage of efficient vaccines and novel therapeutic strategies against HSV are widely global concerns. The abundance on the virion and the major stimulus for the virus-neutralizing antibodies makes gD a predominant candidate f...

주제어

참고문헌 (46)

  1. Awasthi S. Friedman H.M. Status of prophylactic and therapeutic genital herpes vaccines Curr. Opin. Virol. 6 2014 6 12 24631871 

  2. Bag P. Ojha D. Mukherjee H. Halder U.C. Mondal S. Chandra N.S. Nandi S. Sharon A. Sarkar M.C. Chakrabarti S. Chattopadhyay D. An indole alkaloid from a tribal folklore inhibits immediate early event in HSV-2 infected cells with therapeutic efficacy in vaginally infected mice PloS One 8 2013 e77937 

  3. Barnabas R.V. Celum C. Infectious co-factors in HIV-1 transmission herpes simplex virus type-2 and HIV-1: new insights and interventions Curr. HIV Res. 10 2012 228 237 22384842 

  4. Bender F.C. Samanta M. Heldwein E.E. de Leon M.P. Bilman E. Lou H. Whitbeck J.C. Eisenberg R.J. Cohen G.H. Antigenic and mutational analyses of herpes simplex virus glycoprotein B reveal four functional regions J. Virol. 81 2007 3827 3841 17267495 

  5. Burkhart M.D. Kayman S.C. He Y. Pinter A. Distinct mechanisms of neutralization by monoclonal antibodies specific for sites in the N-terminal or C-terminal domain of murine leukemia virus SU J. Virol. 77 2003 3993 4003 12634359 

  6. Cairns T.M. Huang Z.Y. Whitbeck J.C. Ponce de Leon M. Lou H. Wald A. Krummenacher C. Eisenberg R.J. Cohen G.H. Dissection of the antibody response against herpes simplex virus glycoproteins in naturally infected humans J. Virol. 88 2014 12612 12622 25142599 

  7. Cena-Diez R. Vacas-Cordoba E. Garcia-Broncano P. de la Mata F.J. Gomez R. Maly M. Munoz-Fernandez M.A. Prevention of vaginal and rectal herpes simplex virus type 2 transmission in mice: mechanism of antiviral action Int. J. Nanomed. 11 2016 2147 2162 

  8. Cleary K.L. Pare E. Stamilio D. Macones G.A. Type-specific screening for asymptomatic herpes infection in pregnancy: a decision analysis BJOG Int. J. Obstet. Gynaecol. 112 2005 731 736 

  9. Co M.S. Deschamps M. Whitley R.J. Queen C. Humanized antibodies for antiviral therapy Proc. Natl. Acad. Sci. U. S. A. 88 1991 2869 2873 1849279 

  10. Cocchi F. Fusco D. Menotti L. Gianni T. Eisenberg R.J. Cohen G.H. Campadelli-Fiume G. The soluble ectodomain of herpes simplex virus gD contains a membrane-proximal pro-fusion domain and suffices to mediate virus entry Proc. Natl. Acad. Sci. U. S. A. 101 2004 7445 7450 15123804 

  11. de StGroth S.F. Scheidegger D. Production of monoclonal antibodies: strategy and tactics J. Immunol. Methods 35 1980 1 21 7009747 

  12. Dix R.D. Pereira L. Baringer J.R. Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease Infect. Immun. 34 1981 192 199 6271681 

  13. Domeika M. Bashmakova M. Savicheva A. Kolomiec N. Sokolovskiy E. Hallen A. Unemo M. Ballard R.C. Eastern European Network for, S., Reproductive, H Guidelines for the laboratory diagnosis of genital herpes in eastern European countries Euro Surveill. Bull. Eur. les Mal. Transm. Eur. Commun. Disease Bull. 15 2010 

  14. Dropulic L.K. Cohen J.I. The challenge of developing a herpes simplex virus 2 vaccine Expert Rev. Vaccines 11 2012 1429 1440 23252387 

  15. Eisenberg R.J. Atanasiu D. Cairns T.M. Gallagher J.R. Krummenacher C. Cohen G.H. Herpes virus fusion and entry: a story with many characters Viruses 4 2012 800 832 22754650 

  16. Evan G.I. Lewis G.K. Ramsay G. Bishop J.M. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product Mol. Cell. Biol. 5 1985 3610 3616 3915782 

  17. Everett R.D. HSV-1 biology and life cycle Methods Mol. Biol. 1144 2014 1 17 24671673 

  18. Fotouhi F. Soleimanjahi H. Roostaee M.H. Dalimi Asl A. Expression of the herpes simplex virus type 2 glycoprotein D in baculovirus expression system and evaluation of its immunogenicity in Guinea pigs Iran. Biomed. J. 12 2008 59 66 18506211 

  19. Freeman E.E. Weiss H.A. Glynn J.R. Cross P.L. Whitworth J.A. Hayes R.J. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies Aids 20 2006 73 83 16327322 

  20. Fusco D. Forghieri C. Campadelli-Fiume G. The pro-fusion domain of herpes simplex virus glycoprotein D (gD) interacts with the gD N terminus and is displaced by soluble forms of viral receptors Proc. Natl. Acad. Sci. U. S. A. 102 2005 9323 9328 15972328 

  21. Hooks J.J. Burns W. Hayashi K. Geis S. Notkins A.L. Viral spread in the presence of neutralizing antibody: mechanisms of persistence in foamy virus infection Infect. Immun. 14 1976 1172 1178 185150 

  22. Isola V.J. Eisenberg R.J. Siebert G.R. Heilman C.J. Wilcox W.C. Cohen G.H. Fine mapping of antigenic site II of herpes simplex virus glycoprotein D J. Virol. 63 1989 2325 2334 2467994 

  23. Krawczyk A. Krauss J. Eis-Hubinger A.M. Daumer M.P. Schwarzenbacher R. Dittmer U. Schneweis K.E. Jager D. Roggendorf M. Arndt M.A. Impact of valency of a glycoprotein B-specific monoclonal antibody on neutralization of herpes simplex virus J. Virol. 85 2011 1793 1803 21123390 

  24. Krummenacher C. Nicola A.V. Whitbeck J.C. Lou H. Hou W. Lambris J.D. Geraghty R.J. Spear P.G. Cohen G.H. Eisenberg R.J. Herpes simplex virus glycoprotein D can bind to poliovirus receptor-related protein 1 or herpesvirus entry mediator, two structurally unrelated mediators of virus entry J. Virol. 72 1998 7064 7074 9696799 

  25. Lazear E. Whitbeck J.C. Ponce-de-Leon M. Cairns T.M. Willis S.H. Zuo Y. Krummenacher C. Cohen G.H. Eisenberg R.J. Antibody-induced conformational changes in herpes simplex virus glycoprotein gD reveal new targets for virus neutralization J. Virol. 86 2012 1563 1576 22130533 

  26. Looker K.J. Garnett G.P. Schmid G.P. An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection Bull. World Health Organ. 86 2008 805 812 A 18949218 

  27. Looker K.J. Magaret A.S. Turner K.M. Vickerman P. Gottlieb S.L. Newman L.M. Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012 PloS One 10 2015 e114989 

  28. Morrison L.A. Knipe D.M. Mechanisms of immunization with a replication-defective mutant of herpes simplex virus 1 Virology 220 1996 402 413 8661391 

  29. Muggeridge M.I. Wilcox W.C. Cohen G.H. Eisenberg R.J. Identification of a site on herpes simplex virus type 1 glycoprotein D that is essential for infectivity J. Virol. 64 1990 3617 3626 1695252 

  30. Navarro D. Paz P. Pereira L. Domains of herpes simplex virus I glycoprotein B that function in virus penetration, cell-to-cell spread, and cell fusion Virology 186 1992 99 112 1370130 

  31. Nicola A.V. Ponce de Leon M. Xu R. Hou W. Whitbeck J.C. Krummenacher C. Montgomery R.I. Spear P.G. Eisenberg R.J. Cohen G.H. Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM J. Virol. 72 1998 3595 3601 9557640 

  32. Overall J.C. Jr. Herpes simplex virus infection of the fetus and newborn Pediatr. Ann. 23 1994 131 136 8015861 

  33. Parr M.B. Kepple L. McDermott M.R. Drew M.D. Bozzola J.J. Parr E.L. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2 Lab. Investig. J. Tech. Methods Pathol. 70 1994 369 380 

  34. Pereira L. Klassen T. Baringer J.R. Type-common and type-specific monoclonal antibody to herpes simplex virus type 1 Infect. Immun. 29 1980 724 732 6260657 

  35. Pirestani M. Dalimi A. Sarvi S. Khoramabadi N. Evaluation of immunogenicity of novel isoform of EG95 (EG95-5G1) from Echinococcus granulosus in BALB/C mice Iran. J. Parasitol. 9 2014 491 502 25759730 

  36. Sanna P.P. De Logu A. Williamson R.A. Hom Y.L. Straus S.E. Bloom F.E. Burton D.R. Protection of nude mice by passive immunization with a type-common human recombinant monoclonal antibody against HSV Virology 215 1996 101 106 8553581 

  37. Sartori E. Calistri A. Salata C. Del Vecchio C. Palu G. Parolin C. Herpes simplex virus type 2 infection increases human immunodeficiency virus type 1 entry into human primary macrophages Virol. J. 8 2011 166 21486479 

  38. Shin H. Iwasaki A. Generating protective immunity against genital herpes Trends Immunol. 34 2013 487 494 24012144 

  39. Smith J.S. Herrero R. Bosetti C. Munoz N. Bosch F.X. Eluf-Neto J. Castellsague X. Meijer C.J. Van den Brule A.J. Franceschi S. Ashley R. International Agency for Research on Cancer Multicentric Cervical Cancer Study, G Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer J. Natl. Cancer Inst. 94 2002 1604 1613 12419786 

  40. Steiner I. Benninger F. Update on herpes virus infections of the nervous system Curr. Neurol. Neurosci. Rep. 13 2013 414 24142852 

  41. Whitbeck J.C. Muggeridge M.I. Rux A.H. Hou W. Krummenacher C. Lou H. van Geelen A. Eisenberg R.J. Cohen G.H. The major neutralizing antigenic site on herpes simplex virus glycoprotein D overlaps a receptor-binding domain J. Virol. 73 1999 9879 9890 10559300 

  42. Wibmer C.K. Moore P.L. Morris L. HIV broadly neutralizing antibody targets Curr. Opin. HIV AIDS 10 2015 135 143 25760932 

  43. Zeitlin L. Whaley K.J. Sanna P.P. Moench T.R. Bastidas R. De Logu A. Williamson R.A. Burton D.R. Cone R.A. Topically applied human recombinant monoclonal IgG1 antibody and its Fab and F(ab')2 fragments protect mice from vaginal transmission of HSV-2 Virology 225 1996 213 215 8918548 

  44. Zeng F. Hon C.C. Yip C.W. Law K.M. Yeung Y.S. Chan K.H. Malik Peiris J.S. Leung F.C. Quantitative comparison of the efficiency of antibodies against S1 and S2 subunit of SARS coronavirus spike protein in virus neutralization and blocking of receptor binding: implications for the functional roles of S2 subunit FEBS Lett. 580 2006 5612 5620 16989815 

  45. Zhao Y. Cao X. Tang J. Zhou L. Gao Y. Wang J. Zheng Y. Yin S. Wang Y. A novel multiplex real-time PCR assay for the detection and quantification of HPV16/18 and HSV1/2 in cervical cancer screening Mol. Cell. Probes 26 2012 66 72 22293505 

  46. Zou Z. Liu J. Wang Z. Deng F. Wang H. Hu Z. Wang M. Zhang T. Characterization of two monoclonal antibodies, 38F10 and 44D11, against the major envelope fusion protein of Helicoverpa armigera nucleopolyhedrovirus Virol. Sin. 31 2016 490 499 27995421 

관련 콘텐츠

오픈액세스(OA) 유형

BRONZE

출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로